A Group Intervention for Parents of Autistic Young People With Anorexia Nervosa: An Exploration of How Parents Make Sense of and Integrate Concepts From the Group Into Family Life
August 6, 2026 updated by: King's College London
The goal of this study is to understand how a group intervention for parents of autistic young people with co-occurring anorexia nervosa informs how parents support their child's recovery. The main questions it aims to answer are:
- How do parents interpret and understand the concepts learnt in the group intervention? How do parents apply this to day to day family life?
- How do parents understand how autism impacts their child's recovery from anorexia nervosa?
- How do parents make sense of their role in supporting their child's recovery?
Participants will be invited to take part in an interview about their experience of attending the group intervention and applying the concepts to their family life.
Study Overview
Status
Active, not recruiting
Conditions
Study Type
Observational
Enrollment (Estimated)
6
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
London, United Kingdom, SE5 8AZ
- South London and Maudsley Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Parents of autistic young people with anorexia nervosa.
Description
Inclusion Criteria:
- Parents or caregivers of young people (aged 12 to 18) with Autism Spectrum Disorder or elevated autistic traits and anorexia nervosa who are attending/have attended a group parent intervention in MCCAED from November 2024 to February 2026.
- Access and ability to join online interview via Microsoft Teams (participants can join via the Microsoft Teams app or through their browser)
- To have attended at least half of the group intervention
Exclusion Criteria:
- High levels of psychiatric risk & social care involvement; however, this is not a hard exclusion criteria and referrals would still be discussed and considered by the team.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Parent Group 3
Parents who attended the third iteration of the group intervention for parents of autistic young people with anorexia nervosa.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
How do parents interpret and understand the concepts learnt in the group intervention? How do parents apply this to day to day family life?
Time Frame: Nov 2025 - March 2026
|
Nov 2025 - March 2026
|
Other Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
How do parents understand how autism impacts their child's recovery from anorexia nervosa?
Time Frame: Nov 2025 - March 2026
|
Nov 2025 - March 2026
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 26, 2025
Primary Completion (Actual)
July 31, 2026
Study Completion (Estimated)
September 1, 2026
Study Registration Dates
First Submitted
August 6, 2026
First Submitted That Met QC Criteria
August 6, 2026
First Posted (Actual)
August 11, 2026
Study Record Updates
Last Update Posted (Actual)
August 11, 2026
Last Update Submitted That Met QC Criteria
August 6, 2026
Last Verified
August 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 350293 (Other Identifier: South London and Maudsley NHS)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.